+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid treatment in cystic fibrosis related liver disease



Ursodeoxycholic acid treatment in cystic fibrosis related liver disease



Gastroenterology 102(4 Part 2): A862




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144923

Download citation: RISBibTeXText


Related references

Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology 23(6): 1484-1490, 1996

Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease. European Journal of Gastroenterology and Hepatology 8(5): 477-483, 1996

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 2015(12): Cd000222, 2015

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 10: Cd000222, 2012

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 2000(2): Cd000222, 2000

Ursodeoxycholic acid for cystic fibrosis-related liver disease. Cochrane Database of Systematic Reviews 9: Cd000222, 2017

Ursodeoxycholic acid in cystic fibrosis-related liver disease: a systematic review. Journal of the Royal Society of Medicine 90(Suppl. 31): 6-12, 1997

Treatment with ursodeoxycholic acid for patients with cystic fibrosis and liver disease. Escobar, H, Baquero, F, Suarez, L International Congress Series; Clinical ecology of cystic fibrosis 275-279, 1993

Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease. Digestive and Liver Disease 42(6): 428-431, 2010

Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease. Journal of Clinical Gastroenterology 32(4): 324-328, 2001

Clinical outcome of long-term treatment of ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Paumgartner, G, Stiehl, A, Gerok, W Falk Symposium; Bile acids in hepatobiliary diseases: Basic research and clinical application 318-322, 1997

Ursodeoxycholic acid udca treatment improves liver disease and nutritional state in cystic fibrosis cf patients with chronic cholestasis. Gastroenterology 96(5 Part 2): A586, 1989

Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 15(4): 677-684, 1992

Ursodeoxycholic acid in cystic fibrosis-associated liver disease. Journal of Cystic Fibrosis 11(1): 72-3; Author Reply 74-75, 2012

Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease. Journal of Hepatology 31(4): 672-677, 1999